verapamil has been researched along with T-Cell Lymphoma in 9 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Krawczyk, S | 1 |
| Otto, M | 1 |
| Otto, A | 1 |
| Coburger, C | 1 |
| Krug, M | 1 |
| Seifert, M | 1 |
| Tell, V | 1 |
| Molnár, J | 7 |
| Hilgeroth, A | 1 |
| Matos, AM | 1 |
| Reis, M | 1 |
| Duarte, N | 1 |
| Spengler, G | 7 |
| Ferreira, MJ | 1 |
| Domínguez-Álvarez, E | 1 |
| Gajdács, M | 1 |
| Palop, JA | 1 |
| Marć, MA | 1 |
| Kieć-Kononowicz, K | 1 |
| Amaral, L | 2 |
| Jacob, C | 1 |
| Handzlik, J | 2 |
| Sanmartín, C | 1 |
| Paterna, A | 1 |
| Kincses, A | 2 |
| Mulhovo, S | 1 |
| Ferreira, MU | 2 |
| Reis, MA | 1 |
| Ahmed, OB | 1 |
| Lage, H | 1 |
| Kaczor, A | 1 |
| Nové, M | 1 |
| Szymańska, E | 1 |
| Latacz, G | 1 |
| Ocsovszki, I | 1 |
| Tönki, ÁS | 1 |
| Saijo, R | 1 |
| Watanabe, G | 1 |
| Kawase, M | 1 |
| Viveiros, M | 1 |
| Martins, M | 1 |
| Rodrigues, L | 1 |
| Martins, A | 1 |
| Couto, I | 1 |
| Jaffrézou, JP | 1 |
| Levade, T | 1 |
| Thurneyssen, O | 1 |
| Chiron, M | 1 |
| Bordier, C | 1 |
| Attal, M | 1 |
| Chatelain, P | 1 |
| Laurent, G | 1 |
9 other studies available for verapamil and T-Cell Lymphoma
| Article | Year |
|---|---|
Discovery of pyridine-2-ones as novel class of multidrug resistance (MDR) modulators: first structure-activity relationships.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Drug Resistance, | 2011 |
Epoxylathyrol Derivatives: Modulation of ABCB1-Mediated Multidrug Resistance in Human Colon Adenocarcinoma and Mouse T-Lymphoma Cells.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP B | 2015 |
Identification of selenocompounds with promising properties to reverse cancer multidrug resistance.
Topics: Animals; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Cell Line, | 2016 |
Dregamine and tabernaemontanine derivatives as ABCB1 modulators on resistant cancer cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subfamily B; ATP Bindi | 2017 |
Exploring Jolkinol D Derivatives To Overcome Multidrug Resistance in Cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B | 2017 |
Search for ABCB1 Modulators Among 2-Amine-5-Arylideneimidazolones as a New Perspective to Overcome Cancer Multidrug Resistance.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Cel | 2020 |
Fluorinated β-Diketo Phosphorus Ylides Are Novel Inhibitors of the ABCB1 Efflux Pump of Cancer Cells.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; Cell Proliferation; Drug Resistance, Multipl | 2015 |
Demonstration of the activity of P-glycoprotein by a semi-automated fluorometric method.
Topics: Adrenergic Uptake Inhibitors; Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Ca | 2009 |
In vitro and in vivo enhancement of ricin-A chain immunotoxin activity by novel indolizine calcium channel blockers: delayed intracellular degradation linked to lipidosis induction.
Topics: Ammonium Chloride; Antibodies, Monoclonal; Dose-Response Relationship, Drug; Drug Synergism; Humans; | 1992 |